Advanced search
Publication Cover
Clinical Toxicology Volume 58, 2020 - Issue 3
Submit an article Journal homepage
583
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

1,4-Butanediol overdose mimicking toxic alcohol exposure

Maurizio StefaniDepartment of Clinical Pharmacology and Toxicology, St. Vincent’s Hospital, Sydney, Australia; ;St. Vincent’s Clinical School, University of NSW, Sydney, AustraliaView further author information
&
Darren M. RobertsDepartment of Clinical Pharmacology and Toxicology, St. Vincent’s Hospital, Sydney, Australia; ;St. Vincent’s Clinical School, University of NSW, Sydney, AustraliaCorrespondence[email protected]
View further author information
Pages 204-207 | Received 11 Feb 2019, Accepted 02 May 2019, Published online: 20 Jun 2019

References

  • Poldrugo F, Barker S, Basa M, et al. Ethanol potentiates the toxic effects of 1,4-butanediol. Alcoholism Clin Exp Res. 1985;9:493–497.
  • Poldrugo F, Snead OC. 3rd,. 1,4 Butanediol, gamma-hydroxybutyric acid and ethanol: relationships and interactions. Neuropharmacology. 1984;23:109–113.
  • Carai MA, Colombo G, Reali R, et al. Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid. Eur J Pharmacol. 2002;441:157–163.
  • Liakoni E, Gugelmann H, Dempsey DA, et al. Butanediol conversion to gamma-hydroxybutyrate markedly reduced by the alcohol dehydrogenase blocker fomepizole. Clin Pharmacol Ther. 2018;105:1196–1203.
  • Roberts DM, Smith MW, Gopalakrishnan M, et al. Extreme gamma-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis. Ann Emerg Med. 2011;58:83–85.
  • Busardo FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Nueropharmacol. 2015;13:47–70.
  • Schep LJ, Knudsen K, Slaughter RJ, et al. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol. 2012;50:458–470.
  • Zvosec DL, Smith SW, McCutcheon JR, et al. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med. 2001;344:87–94.
  • Thai D, Dyer JE, Jacob P, et al. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Clin Pharmacol Ther. 2007;81:178–184.
  • Lenz D, Jubner M, Bender K, et al. Inhibition of 1,4-butanediol metabolism in human liver in vitro. Naunyn-Schmiedeberg's Arch Pharmacol. 2011;383:647–654.
  • Helrich M, McAslan TC, Skolnik S, et al. Correlation of blood levels of 4-hydroxybutyrate with state of consciousness. Anesthesiology. 1964;25:771–775.
  • Jones AW, Eklund A, Kronstrand R. Concentration-time profiles of gamma-hydroxybutyrate in blood after recreational doses are best described by zero-order rather than first-order kinetics. J Anal Toxicol. 2009;33:332–335.
  • Palatini P, Tedeschi L, Frison G, et al. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol. 1993;45:353–356.
  • Borgen LA, Okerholm R, Morrison D, et al. The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects. J Clin Pharmacol. 2003;43:59–65.
  • Juurlink DN, Roberts DM. The enigma of metformin-associated lactic acidosis. Clin Toxicol. 2014;52:85–87.
  • Ingels M, Kelner MJ, Clark RF. The effect of gamma hydroxybutyrate on serum osmolality. J Toxicol Clin Toxicol. 2001;39:417–418.
  • Wesley JF. Osmolality - a novel and sensitive tool for detection of tampering of beverages adulterated with ethanol, γ-butyrolactone, and 1,4-butanediol, and for detection of dilution-tampered demerol syringes. Microgram Journal. 2003;1:8–17.
  • Krasowski MD, Wilcoxon RM, Miron J. A retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps. BMC Clin Pathol. 2012;12:1.
  • Daly FFS, Little M, Murray L. A risk assessment based approach to the management of acute poisoning. Emerg Med J. 2006;23:396–399.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.